AI Transparency Report
St Joseph Medical Group demonstrates consistent operational growth over the past decade, with revenue increasing from $28.3 million in 2014 to $74.6 million in 2023. The organization generally operates near break-even, with expenses closely tracking revenue, as seen in the 2023 fiscal year where expenses of $76.5 million slightly exceeded revenue of $74.6 million. This indicates a focus on utilizing funds for current operations rather than accumulating large surpluses.
The organization's asset base has shown significant growth, particularly in recent years, jumping from $7.5 million in 2022 to $18.8 million in 2023, and further to $20.7 million in the latest reported period. This suggests investment in infrastructure or operational capacity. A notable aspect of their financial structure is the consistent reporting of 0% officer compensation across all available filings, which enhances their transparency and indicates that executive leadership is not drawing salaries from the nonprofit's funds, or that compensation is reported under other expense categories not specified as 'officer compensation' in the provided data. However, without a detailed breakdown of functional expenses (program, administrative, fundraising), a precise assessment of spending efficiency is limited.
Overall, St Joseph Medical Group appears to be a financially stable and growing entity, effectively managing its resources to meet its operational needs. The lack of reported officer compensation is a positive indicator of financial stewardship, though a more granular view of expense allocation would provide a clearer picture of spending efficiency and program focus.